Clinical Trial Update: Tamoxifen Study [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating tamoxifen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Hypertension
• Myocardial Ischemia

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED